Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

NKp46 Is a Useful Diagnostic Biomarker in Gastrointestinal T-Cell Lymphoproliferative Diseases and Constitutes a Therapeutic Target. a Celac Network Study

Morgane Cheminant, MD, Julie Bruneau, MD PhD, Georgia Malamut, MD PhD, David Sibon, Nicolas Guegan, Sascha Cording, PhD, Amélie Trinquand, MD PhD, Nicole Brousse, MD PhD, Sherine Khater, MD, Elizabeth A. Macintyre, PhD FRCP, FRCPath, Vahid Asnafi, MD PhD, Laurent Pouyet, PhD, Florence Lhospice, PharmD, Thierry Jo Molina, MDPhD, Bertrand Meresse, PhD, Christophe Cellier, MD PhD, Nadine Cerf-Bensussan, MD PhD, Olivier Hermine, MD PhD

Blood (2017) 130 (Supplement 1): 2820.

https://doi.org/10.1182/blood.V130.Suppl_1.2820.2820

Published: 2017

Journal Articles

Tumor Cell Proliferation (Ki-67 Index) Overcomes Cytology and Growth Pattern As Prognostic Factor in Mantle-Cell Lymphoma – Results from Randomized Trials of the European MCL Network

Eva Hoster, PhD, Andreas Rosenwald, MD, Francoise Berger, MD PhD, Heinz-Wolfram Bernd, Sylvia Hartmann, Christoph Loddenkemper, Thomas Barth, Nicole Brousse, Stefano Pileri, Grzegorz Rymkiewicz, Roman Kodet, Michael Unterhalt, MD, Johanna C. Kluin-Nelemans, Olivier Hermine, MD PhD, Wolfgang Hiddemann, MD PhD, Martin H. Dreyling, Wolfram Klapper, MD

Blood (2014) 124 (21): 2977.

https://doi.org/10.1182/blood.V124.21.2977.2977

Published: 2014

Journal Articles

Histological Characteristics of Ataxia Telangiectasia Associated Lymphoproliferative Diseases. Results of the French Registry of Primary Immune Deficiencies

Danielle Canioni, MD, Nizar Mahlaoui, MD MSc, MPH, Chantal Andriamanga, MD, Catherine Dubois d'Enghien, Jean-Philippe Jais, MD PhD, Alain Fischer, MD PhD, Olivier Hermine, MD PhD, Nicole Brousse, Dominique Stoppa-Lyonnet, Felipe Suarez, MD PhD

Blood (2014) 124 (21): 1634.

https://doi.org/10.1182/blood.V124.21.1634.1634

Published: 2014

Journal Articles

Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients

Blood (2014) 124 (10): 1597–1609.

https://doi.org/10.1182/blood-2014-02-553834

Published: 2014

Includes: Supplemental data

Journal Articles

A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency

Blood (2013) 122 (23): 3713–3722.

https://doi.org/10.1182/blood-2013-06-508267

Published: 2013

Includes: Supplemental data

Journal Articles

Enteropathy-Associated T-Cell Lymphoma Type I, But Not Refractory Celiac Disease, Strongly Expresses CD30 and Might Benefit From Brentuximab Vedotin

David Sibon, MD, PhD, Georgia Malamut, MD, PhD, Virginie Verkarre, MD, PhD, Coralie Derrieux, MD, Isabelle Radford, MD, Bertrand Meresse, PhD, Elizabeth Macintyre, MD, PhD, Christophe Cellier, MD, PhD, Nadine Cerf-Bensussan, MD, PhD, Nicole Brousse, M.D., Olivier Hermine

Blood (2013) 122 (21): 4252.

https://doi.org/10.1182/blood.V122.21.4252.4252

Published: 2013

Journal Articles

CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte

Richard Delarue, Corinne Haioun, Vincent Ribrag, Pauline Brice, Alain Delmer, Herve Tilly, Gilles Salles, Achiel Van Hoof, Olivier Casasnovas, Nicole Brousse, Francois Lefrere, Olivier Hermine

Blood (2013) 121 (1): 48–53.

https://doi.org/10.1182/blood-2011-09-370320

Published: 2013

Includes: Supplemental data

Journal Articles

Alternating Courses of 3x CHOP and 3x DHAP Plus Rituximab Followed by a High Dose ARA-C Containing Myeloablative Regimen and Autologous Stem Cell Transplantation (ASCT) Increases Overall Survival When Compared to 6 Courses of CHOP Plus Rituximab Followed by Myeloablative Radiochemotherapy and ASCT in Mantle Cell Lymphoma: Final Analysis of the MCL Younger Trial of the European Mantle Cell Lymphoma Network ( MCL net )

Blood (2012) 120 (21): 151.

https://doi.org/10.1182/blood.V120.21.151.151

Published: 2012

Journal Articles

High Level of CD71 Expression On Neoplastic B Cells At Diagnosis Is Predictive of Overall Survival After Rituximab and Anthracyclines Based Regimen in Follicular Lymphoma

FS de Fontbrune, M.D., M. Sc., Danielle Canioni, MD, Hugo Chapdelaine, M.D., Richard Delarue, MD, Nicole Brousse, M.D., Felipe Suarez, MD, PhD, Olivier Hermine, MD, PhD

Blood (2012) 120 (21): 1601.

https://doi.org/10.1182/blood.V120.21.1601.1601

Published: 2012

Journal Articles

A Mendelian Predisposition to B Cell Lymphoma Caused by IL-10R2 Deficiency

Blood (2012) 120 (21): 5092.

https://doi.org/10.1182/blood.V120.21.5092.5092

Published: 2012

Journal Articles

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

Blood (2012) 120 (13): 2700–2703.

https://doi.org/10.1182/blood-2012-05-430140

Published: 2012

Journal Articles

Loss of p19Arf in a Rag1 −/− B-cell precursor population initiates acute B-lymphoblastic leukemia

Julia Hauer, Charles Mullighan, Estelle Morillon, Gary Wang, Julie Bruneau, Nicole Brousse, Marc Lelorc'h, Serge Romana, Amine Boudil, Daniela Tiedau, Sven Kracker, Frederic D. Bushmann, Arndt Borkhardt, Alain Fischer, Salima Hacein-Bey-Abina, Marina Cavazzana-Calvo

Blood (2011) 118 (3): 544–553.

https://doi.org/10.1182/blood-2010-09-305383

Published: 2011

Includes: Supplemental data

Journal Articles

Association of Langerhans Cell Histiocytosis with Erdheim-Chester Disease: How Close Monocyte/Macrophage and Dendritic Cell Lineages Are?

Baptiste Hervier, MD, Julien Haroche, MD, PhD, Olivier Hermine, MD, PhD, Jean Donadieu, MD, PhD, Frederic Charlotte, MD, Nicole Brousse, Eric Hachulla, MD, PhD, Zahir Amoura

Blood (2010) 116 (21): 4716.

https://doi.org/10.1182/blood.V116.21.4716.4716

Published: 2010

Journal Articles

Alternating Courses of 3x CHOP and 3x DHAP Plus Rituximab Followed by a High Dose ARA-C Containing Myeloablative Regimen and Autologous Stem Cell Transplantation (ASCT) Is Superior to 6 Courses CHOP Plus Rituximab Followed by Myeloablative Radiochemotherapy and ASCT In Mantle Cell Lymphoma: Results of the MCL Younger Trial of the European Mantle Cell Lymphoma Network ( MCL net )

Blood (2010) 116 (21): 110.

https://doi.org/10.1182/blood.V116.21.110.110

Published: 2010

Journal Articles

Leukemia Prone B-Precursor Population in a p19ARF-/-RAG1-/- Mouse Model.

Julia Hauer, MD, Charles G. Mullighan, MBBS(Hons), MSc, MD, Estelle Morillon, Gary P Wang, MD, PhD, Julie Bruneau, Nicole Brousse, Arndt Borkhardt, MD, Frederic D Bushmann, PhD, Alain Fischer, MD, PhD, Salima Hacein-Bey-Abina, Pharm.D., Ph.D., Marina Cavazzana-Calvo, MD, PhD

Blood (2009) 114 (22): 3971.

https://doi.org/10.1182/blood.V114.22.3971.3971

Published: 2009

Journal Articles

The Type of Enteropathy Is a Prognostic Factor in Enteropathy-Associated T-Cell Lymphoma.

Marie-Olivia Chandesris, Georgia Malamut, Virginie Verkarre, Bertrand Meresse, Gabriel Rahmi, Elizabeth Macintyre, Nicole Brousse, Nadine Cerf-Bensussan, Christophe Cellier, Olivier Hermine

Blood (2009) 114 (22): 2937.

https://doi.org/10.1182/blood.V114.22.2937.2937

Published: 2009

Journal Articles

RCHOP and RDHAP Followed by Autologous Stem Cell Transplantation (ASCT) in Mantle Cell Lymphoma (MCL) : Final Results of a Phase II Study from the GELA

Richard Delarue, Corinne Haioun, Vincent Ribrag, Pauline Brice, Alain Delmer, Herve Tilly, Gilles Salles, Achiel Van Hoof, Olivier Casasnovas, Nicole Brousse, Francois Lefrere, Olivier Hermine

Blood (2008) 112 (11): 581.

https://doi.org/10.1182/blood.V112.11.581.581

Published: 2008

Journal Articles

Imatinib mesylate for platelet-derived growth factor receptor-beta–positive Erdheim-Chester histiocytosis

Julien Haroche, Zahir Amoura, Frédéric Charlotte, Juan Salvatierra, Bertrand Wechsler, Carlos Graux, Nicole Brousse, Jean-Charles Piette

Blood (2008) 111 (11): 5413–5415.

https://doi.org/10.1182/blood-2008-03-148304

Published: 2008

Journal Articles

The Poor Prognosis Value of High Intra-Tumoral Macrophages Counts in Follicular Lymphoma Patients Requires Selection of Appropriate Cut-Off and Can Be Circumvented by Rituximab Therapy.

Danielle Canioni, Gilles Salles, Nicolas Mounier, Nicole Brousse, Marie Keuppens, Frank Morchauser, Marion Fournier, Thierry Lamy, Marie-Christine Rousselet, Charles Foussard, Luc Xerri

Blood (2006) 108 (11): 822.

https://doi.org/10.1182/blood.V108.11.822.822

Published: 2006

Journal Articles

Single Treatment with Rituximab Monotherapy for Low-Tumor Burden Follicular Lymphoma (FL): Survival Analyses with Extended Follow-Up (F/Up) of 7 Years.

Blood (2006) 108 (11): 486.

https://doi.org/10.1182/blood.V108.11.486.486

Published: 2006

NARROW

NKp46 Is a Useful Diagnostic Biomarker in Gastrointestinal T-Cell Lymphoproliferative Diseases and Constitutes a Therapeutic Target. a Celac Network Study

Tumor Cell Proliferation (Ki-67 Index) Overcomes Cytology and Growth Pattern As Prognostic Factor in Mantle-Cell Lymphoma – Results from Randomized Trials of the European MCL Network

Histological Characteristics of Ataxia Telangiectasia Associated Lymphoproliferative Diseases. Results of the French Registry of Primary Immune Deficiencies

Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients

A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency

Enteropathy-Associated T-Cell Lymphoma Type I, But Not Refractory Celiac Disease, Strongly Expresses CD30 and Might Benefit From Brentuximab Vedotin

CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte

High Level of CD71 Expression On Neoplastic B Cells At Diagnosis Is Predictive of Overall Survival After Rituximab and Anthracyclines Based Regimen in Follicular Lymphoma

A Mendelian Predisposition to B Cell Lymphoma Caused by IL-10R2 Deficiency

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

Loss of p19Arf in a Rag1 −/− B-cell precursor population initiates acute B-lymphoblastic leukemia

Association of Langerhans Cell Histiocytosis with Erdheim-Chester Disease: How Close Monocyte/Macrophage and Dendritic Cell Lineages Are?

Leukemia Prone B-Precursor Population in a p19ARF-/-RAG1-/- Mouse Model.

The Type of Enteropathy Is a Prognostic Factor in Enteropathy-Associated T-Cell Lymphoma.

RCHOP and RDHAP Followed by Autologous Stem Cell Transplantation (ASCT) in Mantle Cell Lymphoma (MCL) : Final Results of a Phase II Study from the GELA

Imatinib mesylate for platelet-derived growth factor receptor-beta–positive Erdheim-Chester histiocytosis

The Poor Prognosis Value of High Intra-Tumoral Macrophages Counts in Follicular Lymphoma Patients Requires Selection of Appropriate Cut-Off and Can Be Circumvented by Rituximab Therapy.

Single Treatment with Rituximab Monotherapy for Low-Tumor Burden Follicular Lymphoma (FL): Survival Analyses with Extended Follow-Up (F/Up) of 7 Years.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only